NMT Looking To Broaden STARFlex Indication In Wake Of Panel Outcome
This article was originally published in The Gray Sheet
Executive Summary
NMT Medical is in discussions with FDA on the design of a trial to support a general stroke-prevention indication for its STARFlex patent foramen ovale (PFO) occluder